Hyderabad: After waiting for over seven years after filing its application on the drug, Dr Reddy???s Laboratories (DRL) has finally launched its generic version of hypertension drug Lotrel in the US market.
The company has launched the amlodipine benazepril capsules in 2.5mg/10mg, 5mg/10mg, 5mg/20mg, 10mg/20mg strengths.
Teva, Lupin, Sandoz and Novartis are already marketing the drug in the US, making DRL the fifth company to enter the market.
According to market sources, the drug has annual sales of about $527 million. Company officials refused to divulge the targeted market share.
Though being seen as a credible opportunity, the market is likely to see further competition with Mylan and Cobalt too waiting for the expiry of the 30-month stay on their applications.
K V Ramana / DNA